PRESS RELEASE - METOMIL
04/10/2007
PRESS RELEASE - METOMIL
Em 19 de setembro de 2007 a Comissão Europeia publicou a decisão relativa à reavaliação da nossa substância activa metomil. Infelizmente a decisão foi de “não inclusão”.
A DuPont considera que este desfecho negativo resultou do facto da Comissão Europeia ter bloqueado a avaliação técnica do metomil, não tendo sido considerada parte da informação disponível. Assim, a decisão tomada com vista à inclusão no Anexo I baseou-se numa avaliação incompleta do dossier apresentado.
Por acreditar de forma inequívoca na existência de usos seguros para o metomil, e consequentemente na sua futura proposta de inclusão no Anexo I, a DuPont decidiu voltar a apresentar o seu pedido de inclusão. O dossier necessário à respectiva avaliação já foi apresentado às autoridades inglesas (Plant Safety Directorate) que aceitaram continuar como Estado Membro Relator para o metomil. A avaliação do dossier apresentado já foi iniciada.
O Lannate®, produto DuPont à base de metomilo, é um insecticida de largo espectro registado em mais de 70 países para o controlo de mais de 140 pragas em 165 culturas.
A preponderância dos estudos científicos disponíveis, bem como a experiência prática da sua utilização agronómica ao longo de 30 anos, comprovam que o Lannate® pode ser usado da mesma forma segura pelo agricultor no controlo das suas pragas, com um impacto ambiental mínimo e com um nível de resíduos nas culturas tratadas nulo ou muito reduzido sempre que aplicado de acordo com o indicado no respectivo rótulo.
A DuPont continua comprometida em assegurar que o Lannate® continuará a encontrar-se disponível nos importantes mercados agrícolas da Europa.
Non-inclusion of methomyl in Annex I of Directive 91/414/EEC
Bad Homburg, 2nd October, 2007
On 19th September 2007, the Commission published its decision regarding the status of methomyl in Annex I of Directive 91/414/EEC. The decision is unfortunately ‘non-inclusion’.
DuPont considers that this negative outcome primarily results from a decision by the Commission to freeze the technical evaluation at a certain stage, ignoring some of the available information and the making of an Annex 1 decision on the basis of an incomplete assessment.
Because we firmly believe that safe uses can unambiguously be demonstrated and therefore inclusion in Annex 1 be proposed when all available information is considered, DuPont has decided to re-apply for inclusion on methomyl in Annex 1. The corresponding dossier has been submitted to, and is being evaluated by, the UK (Plant Safety Directorate), which accepted to remain the Rapporteur Member State for methomyl.
Lannate®, the DuPont product containing the active ingredient methomyl, is a broad spectrum, fast acting insecticide that has been registered on 165 crops to control more than 140 pest species in more than 70 countries.
The preponderance of scientific evidence and over thirty years of practical agronomic experience suggests that Lannate® can be used safely by the grower to manage his insect pests with minimal environmental impact and little or no food residue.
DuPont remains committed to ensuring that Lannate® products will continue to be available in the important agricultural markets in Europe.
DuPont is a science company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture, nutrition, electronics, communications, safety and protection, home and construction, transportation and apparel.
For additional information about our company or our products, check our worldwide Web site: http://www.cropprotection.dupont.com
Press contact DuPont Crop Protection Europe, Middle East, Africa
Dr. Verena Rappaport, DuPont Straße 1, 61352 Bad Homburg v.d.H., Germany
Phone:+49 6172 87 1463, Fax: +49 6172 87 1402, Mobile: +49 173 27 28 266, Email: verena.rappaport@deu.dupont.com
Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont’s filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.
